These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 19851216

  • 1. Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?
    Valgimigli M, Airoldi F, Zimarino M.
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10 Suppl 1():S17-26. PubMed ID: 19851216
    [Abstract] [Full Text] [Related]

  • 2. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL, Steinberg DH, Roy P, Javaid A, Buch AN, Okabe T, Xue Z, Smith K, Torguson R, Pichard AD, Satler LF, Suddath WO, Kent KM, Waksman R.
    Cardiovasc Revasc Med; 2008 Oct; 9(1):24-8. PubMed ID: 18206634
    [Abstract] [Full Text] [Related]

  • 3. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [Abstract] [Full Text] [Related]

  • 4. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):323-32. PubMed ID: 19360858
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F, Tomai F, De Luca G, Boccuzzi G, Presbitero P, Pesarini G, Ferrero V, Ghini AS, Pastori F, De Luca L, Zavalloni D, Soregaroli D, Garbo R, Franchi E, Marino P, Minelli M, Vassanelli C.
    J Cardiovasc Med (Hagerstown); 2009 Feb 01; 10(2):192-9. PubMed ID: 19377384
    [Abstract] [Full Text] [Related]

  • 6. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
    Morrison DA, Berman M, El-Amin O, McLaughlin RT, Bates ER.
    Minerva Cardioangiol; 2007 Oct 01; 55(5):593-623. PubMed ID: 17912165
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
    Campo G, Saia F, Percoco G, Manari A, Santarelli A, Vignali L, Varani E, Benassi A, Sangiorgio P, Tarantino F, Magnavacchi P, De Palma R, Guastaroba P, Marzocchi A.
    Int J Cardiol; 2010 Apr 15; 140(2):154-60. PubMed ID: 19056134
    [Abstract] [Full Text] [Related]

  • 8. Drug-eluting stents versus bare-metal stents in acute ST-segment elevation myocardial infarction. a single-center experience with long-term follow up.
    Palmieri C, Ravani M, Trianni G, Gianetti J, Vaghetti M, Rizza A, Paradossi U, Beqiri A, Berti S.
    J Invasive Cardiol; 2010 Apr 15; 22(4):151-8. PubMed ID: 20351384
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
    Hamirani YS, Jibrin I, Abraham D, Merriman B, Wenz C, Bahr RD.
    Crit Pathw Cardiol; 2008 Dec 15; 7(4):232-8. PubMed ID: 19050419
    [Abstract] [Full Text] [Related]

  • 10. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S, Hoffmeister HM, Bode C.
    Herz; 2008 Jun 15; 33(4):244-53. PubMed ID: 18581073
    [Abstract] [Full Text] [Related]

  • 11. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes.
    Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC.
    Circ Cardiovasc Interv; 2009 Feb 15; 2(1):35-42. PubMed ID: 20031691
    [Abstract] [Full Text] [Related]

  • 12. Drug-eluting stents in primary percutaneous coronary intervention for ST-elevation myocardial infarction: an up-to-date review of the literature.
    Ehdaie A, Lee MS.
    Minerva Cardioangiol; 2009 Oct 15; 57(5):645-55. PubMed ID: 19838154
    [Abstract] [Full Text] [Related]

  • 13. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):594-8. PubMed ID: 18311841
    [Abstract] [Full Text] [Related]

  • 14. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr 01; 18(100):70-4. PubMed ID: 19585727
    [Abstract] [Full Text] [Related]

  • 15. Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and design.
    Tamburino C, Capodanno D, La Manna A, di Salvo M, Sanfilippo A, Prati F.
    J Cardiovasc Med (Hagerstown); 2010 Jan 01; 11(1):53-8. PubMed ID: 19829136
    [Abstract] [Full Text] [Related]

  • 16. Evidence-based management of patients undergoing PCI: stent controversies.
    Vetrovec GW.
    Catheter Cardiovasc Interv; 2010 Mar 01; 75 Suppl 1():S39-42. PubMed ID: 20333706
    [Abstract] [Full Text] [Related]

  • 17. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
    Daemen J, Tanimoto S, García-García HM, Kukreja N, van de Sande M, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW.
    Am J Cardiol; 2007 Apr 15; 99(8):1027-32. PubMed ID: 17437722
    [Abstract] [Full Text] [Related]

  • 18. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A.
    Circulation; 2007 Jun 26; 115(25):3181-8. PubMed ID: 17562952
    [Abstract] [Full Text] [Related]

  • 19. The use of drug-eluting stents in venous coronary artery bypass grafts.
    Hernandez-Antolín R, Alfonso F, Jimenez P.
    EuroIntervention; 2009 May 26; 5 Suppl D():D51-7. PubMed ID: 19736072
    [Abstract] [Full Text] [Related]

  • 20. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
    Kedia G, Lee MS.
    Catheter Cardiovasc Interv; 2007 May 01; 69(6):782-9. PubMed ID: 17394249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.